Medtech & Pharma Platform Association

🔗 Connecting Health Sectors for Better Patient Solutions 🔗 At the Medtech & Pharma Platform Association (MPP), one of our missions is to foster synergies across the medtech, diagnostic, pharmaceutical, and digital health sectors. We are focused on advancing health technologies through an integrated approach that includes: 🌐 Medicinal products for effective treatments 🌐 Medical devices for accurate drug delivery, diagnostic and monitoring 🌐 Digital platforms like medical software and mobile solutions for patient support Through collaboration, MPP is shaping a more holistic healthcare landscape where medicines, devices, and digital solutions come together to drive innovation and improve patient outcomes. This week, we take the time to thank you, our members, partners and followers, for your contribution to our work. Your drive. Your trust and solidarity. And your commitment to tomorrow’s safe, available and efficient health products for all patients’ well-being.

Season’s Greetings from the MPP Association! 🎄✨ As we approach the end of 2024, we would like to take a moment to thank all our members, partners, and collaborators for their continued support and engagement throughout the year. At the MPP Association, we remain committed to advancing the development and regulation of combined health technologies by: 🔹 Contributing to surveys and public consultations to identify key challenges and propose actionable recommendations. 🔹 Organizing expert events to deliver in-depth insights on the latest advancements in health technologies. 🔹 Hosting our flagship conference, bringing together industry leaders, experts, and innovators to share knowledge, showcase products, and foster valuable connections. We look forward to another year of collaboration, progress, and innovation. Wishing you a festive holiday and a Happy New Year filled with health, happiness, and success! 🎉 Let’s continue to drive impactful change in 2025!

EU Member States endorsed the COMBINE program, which aims to streamline combined studies involving medicinal products, medical devices and IVDs. Combined trials play a key role in the development of innovative treatments and in increasing access for patients. The Medtech & Pharma Platform Association has been actively involved in the COMBINE project and looks forward to be further contributing to the program along with other stakeholders. #Medtech #IVDs #MedicinalProducts

🌟 Join Us at the Medtech & Pharma Platform Association (MPP)! Are you passionate about improving healthcare and innovation in the pharma and medtech sectors? Become part of a dynamic community dedicated to enhancing access to combined products, integrating pharma, medtech, diagnostic and digital products, fostering collaboration across industries. 🤝 Why Join Us? 📍  Network with key industry players 📍  Share insights and your expertise 📍  Influence policy and drive change Together, we can make a real impact! Visit our website to learn more and become a member today: https://bit.ly/3K7yWvc #HealthInnovation #pharma #medicaldevices #medtech

🔬 MPP Association’s In Vitro Diagnostics Working Group 🔬 The Medtech & Pharma Platform Association's IVD Working Group tackles regulatory and policy issues related to in vitro diagnostics (IVDs), with a focus on IVDs used in combination with medicinal products. The WG led the preparation of our paper on the impact of IVDR on the use of in-house devices in clinical trials issued in October. 💡 Is this topic relevant to you? Join us in our efforts to accelerate patients’ access to safe and innovative health technologies and reinforce the competitiveness of the European healthcare industry. 🔎 Read the paper here: https://bit.ly/3OHWzNd Learn more about MPP activities or contact us directly: https://bit.ly/3K7yWvc #InVitroDiagnostics #IVDR #regulatorycompliance #medicaldevices #medtech

🌐 MPP Association's Connected Combined Products Working Group!🌐 Our Connected Combined Products WG is at the forefront of policy and regulatory discussions around combined products incorporating software, mobile platforms, and cloud applications. 📱📶 🔍 What’s our mission? To engage in ongoing EU discussions on strategic and regulatory frameworks like: ▪️ The Artificial Intelligence Act (entry into force in 2024) ▪️ The Multi-annual AI Workplan (2023-2028) ▪️ The European Medicines Agencies Network Strategy 2028 Our goal is to ensure proportionate and safe regulation for these cutting-edge products while supporting the integration of new technologies in healthcare. ✨ What are Connected Combined Products (CCPs)? We define a CCP as any medicinal product used with two or more components - such as devices, IVDs, software, mobile platforms, or cloud applications - designed to deliver medicine to patients and track essential data like medical adherence. Learn more about MPP activities or contact us directly: https://bit.ly/3K7yWvc

🔬 MPP Association's Combined Products Working Group! 🔬 The Medtech & Pharma Platform Association’s Working Groups create a collaborative space for members to tackle complex regulatory and policy issues in specific areas. The Combined Products Working Group (WG), focuses on the unique challenges of drug/device combinations in the EU regulatory landscape. 💼 What’s in focus? The WG dives into the policy and regulatory specifics of drug/device combinations, such as: ➡️ Integral combinations governed by Article 117 of the MDR ➡️ Cross-labeled and co-packaged drug/device combinations By actively contributing to EU-level discussions, we work to shape the regulatory landscape around MDR/IVDR assessments, ultimately helping to bring safe and innovative combined products to market efficiently. 💡How does MPP define “Combined Products”? We define a combined product as any use of a medicinal product (including biologics and ATMPs) with a device or diagnostic tool, designed for medical purposes. This category spans a wide range of products, including e-/m-health solutions. Learn more about the MPP’s activities and members: https://bit.ly/3K7yWvc

📢 In October, the Medtech & Pharma Platform Association has shared with the European Commission key aspects on which our members would welcome solutions as part of the expected evaluation of the Medical Devices and In Vitro Diagnostics Regulations (MDR & IVDR). One of the key challenges highlighted in this letter relates to  combined products using medical device technology platform, such as syringes injection pens, autoinjectors and inhalers. Those medical device technology platforms often rely on well-known legacy products. Although the same medical device technology platform is used in multiple combined products, this device part is nevertheless subject to repeated reviews under MDR Art. 117, resulting in the need for multiple applications. The MPP Association also draws attention to other challenges currently faced by MPP members in relation to the MDR compliance, which concern scientific advice; the alignment of advice across regulators and Notified Bodies when assessing aspects like the summary of product characteristics (SmPC) and the package leaflet (PL) of co-packaged combined products; the lifecycle management of combined products; the repackaging/relabelling of medical devices; and post-market requirements for co-packaged medical devices. See all proposed solutions by the MPP Association here📄 https://bit.ly/3NNd3mC #MedicalDevices #IVDR #MDR #HealthcareInnovation #RegulatoryCompliance

🌐 Join the MPP Association and lead the future of health innovation 🌐 The Medtech & Pharma Platform Association brings together key companies across the pharmaceutical, medtech, and diagnostic sectors that are actively working on developing and improving access to combined products. Here’s how MPP membership empowers you to make an impact: 🔹 Policy dialogue: Contribute to working groups and engage with regulators to proactively shape future healthcare policy & regulation 🔹 Insights: Stay ahead with updates on policy changes impacting combined products 🔹 Networking: Connect with key stakeholders to drive innovative healthcare solutions 🔹 Access to expertise: Benefit from a network and a robust knowledge pool for combined products 🔹 Membership benefits: Enjoy reduced rates at the MPP Annual Conference and access to other events 📈 Join us to shape tomorrow's health solutions: https://bit.ly/3KGx1hz #CombinedProducts #Pharma #Medtech #IVDs

💡 Stay ahead with the Medtech & Pharma Platform Association! 💡 The MPP Association is dedicated to fostering knowledge exchange by organizing expert events that offer comprehensive, up-to-date insights on the latest developments in combined health technologies. 🔍 If you're passionate about improving access to combined products and strengthening cross-sectoral synergies, we invite you to join us in shaping the future of healthcare. 🌐 👉 Learn more and become a member today: https://bit.ly/3KGx1hz #Medtech #Pharma #Innovation